2-[(2S)-2-benzyl-4-(2,3-dihydro-1,4-benzodioxin-6-ylmethyl)-3,6-dioxopiperazin-1-yl]-N-[3-methyl-1-[5-[[3-methyl-5-(trifluoromethyl)phenyl]methyl]-1,3,4-oxadiazol-2-yl]-1-oxobutan-2-yl]acetamide;2-[(5S)-3,5-dibenzyl-2,4-dioxoimidazolidin-1-yl]-N-[3-methyl-1-[5-[(3-methylphenyl)methyl]-1,3,4-oxadiazol-2-yl]-1-oxobutan-2-yl]acetamide;N-[3-methyl-1-[5-[(3-methylphenyl)methyl]-1,3,4-oxadiazol-2-yl]-1-oxobutan-2-yl]-2-[3-(2-morpholin-4-ylethyl)-2,5-dioxo-4-phenylimidazolidin-1-yl]acetamide;N-[3-methyl-1-oxo-1-[5-[[3-(trifluoromethyl)phenyl]methyl]-1,2,4-oxadiazol-3-yl]butan-2-yl]-2-[3-(2-morpholin-4-ylethyl)-2,5-dioxo-4-phenylimidazolidin-1-yl]acetamide;pyridin-4-ylmethyl N-[(2S)-3-methyl-1-[(2S)-2-[[(2S)-3-methyl-1-[5-[(3-methylphenyl)methyl]-1,3,4-oxadiazol-2-yl]-1-oxobutan-2-yl]carbamoyl]pyrrolidin-1-yl]-1-oxobutan-2-yl]carbamate

C168H186F6N28O30 — CID 159208112

About 2-[(2S)-2-benzyl-4-(2,3-dihydro-1,4-benzodioxin-6-ylmethyl)-3,6-dioxopiperazin-1-yl]-N-[3-methyl-1-[5-[[3-methyl-5-(trifluoromethyl)phenyl]methyl]-1,3,4-oxadiazol-2-yl]-1-oxobutan-2-yl]acetamide;2-[(5S)-3,5-dibenzyl-2,4-dioxoimidazolidin-1-yl]-N-[3-methyl-1-[5-[(3-methylphenyl)methyl]-1,3,4-oxadiazol-2-yl]-1-oxobutan-2-yl]acetamide;N-[3-methyl-1-[5-[(3-methylphenyl)methyl]-1,3,4-oxadiazol-2-yl]-1-oxobutan-2-yl]-2-[3-(2-morpholin-4-ylethyl)-2,5-dioxo-4-phenylimidazolidin-1-yl]acetamide;N-[3-methyl-1-oxo-1-[5-[[3-(trifluoromethyl)phenyl]methyl]-1,2,4-oxadiazol-3-yl]butan-2-yl]-2-[3-(2-morpholin-4-ylethyl)-2,5-dioxo-4-phenylimidazolidin-1-yl]acetamide;pyridin-4-ylmethyl N-[(2S)-3-methyl-1-[(2S)-2-[[(2S)-3-methyl-1-[5-[(3-methylphenyl)methyl]-1,3,4-oxadiazol-2-yl]-1-oxobutan-2-yl]carbamoyl]pyrrolidin-1-yl]-1-oxobutan-2-yl]carbamate

2-[(2S)-2-benzyl-4-(2,3-dihydro-1,4-benzodioxin-6-ylmethyl)-3,6-dioxopiperazin-1-yl]-N-[3-methyl-1-[5-[[3-methyl-5-(trifluoromethyl)phenyl]methyl]-1,3,4-oxadiazol-2-yl]-1-oxobutan-2-yl]acetamide;2-[(5S)-3,5-dibenzyl-2,4-dioxoimidazolidin-1-yl]-N-[3-methyl-1-[5-[(3-methylphenyl)methyl]-1,3,4-oxadiazol-2-yl]-1-oxobutan-2-yl]acetamide;N-[3-methyl-1-[5-[(3-methylphenyl)methyl]-1,3,4-oxadiazol-2-yl]-1-oxobutan-2-yl]-2-[3-(2-morpholin-4-ylethyl)-2,5-dioxo-4-phenylimidazolidin-1-yl]acetamide;N-[3-methyl-1-oxo-1-[5-[[3-(trifluoromethyl)phenyl]methyl]-1,2,4-oxadiazol-3-yl]butan-2-yl]-2-[3-(2-morpholin-4-ylethyl)-2,5-dioxo-4-phenylimidazolidin-1-yl]acetamide;pyridin-4-ylmethyl N-[(2S)-3-methyl-1-[(2S)-2-[[(2S)-3-methyl-1-[5-[(3-methylphenyl)methyl]-1,3,4-oxadiazol-2-yl]-1-oxobutan-2-yl]carbamoyl]pyrrolidin-1-yl]-1-oxobutan-2-yl]carbamate (PubChem CID 159208112) has the molecular formula C168H186F6N28O30 and a molecular weight of 3191.49 g/mol. Its IUPAC name is 2-[(2S)-2-benzyl-4-(2,3-dihydro-1,4-benzodioxin-6-ylmethyl)-3,6-dioxopiperazin-1-yl]-N-[3-methyl-1-[5-[[3-methyl-5-(trifluoromethyl)phenyl]methyl]-1,3,4-oxadiazol-2-yl]-1-oxobutan-2-yl]acetamide;2-[(5S)-3,5-dibenzyl-2,4-dioxoimidazolidin-1-yl]-N-[3-methyl-1-[5-[(3-methylphenyl)methyl]-1,3,4-oxadiazol-2-yl]-1-oxobutan-2-yl]acetamide;N-[3-methyl-1-[5-[(3-methylphenyl)methyl]-1,3,4-oxadiazol-2-yl]-1-oxobutan-2-yl]-2-[3-(2-morpholin-4-ylethyl)-2,5-dioxo-4-phenylimidazolidin-1-yl]acetamide;N-[3-methyl-1-oxo-1-[5-[[3-(trifluoromethyl)phenyl]methyl]-1,2,4-oxadiazol-3-yl]butan-2-yl]-2-[3-(2-morpholin-4-ylethyl)-2,5-dioxo-4-phenylimidazolidin-1-yl]acetamide;pyridin-4-ylmethyl N-[(2S)-3-methyl-1-[(2S)-2-[[(2S)-3-methyl-1-[5-[(3-methylphenyl)methyl]-1,3,4-oxadiazol-2-yl]-1-oxobutan-2-yl]carbamoyl]pyrrolidin-1-yl]-1-oxobutan-2-yl]carbamate.

Molecular Properties

• Compound Name: 2-[(2S)-2-benzyl-4-(2,3-dihydro-1,4-benzodioxin-6-ylmethyl)-3,6-dioxopiperazin-1-yl]-N-[3-methyl-1-[5-[[3-methyl-5-(trifluoromethyl)phenyl]methyl]-1,3,4-oxadiazol-2-yl]-1-oxobutan-2-yl]acetamide;2-[(5S)-3,5-dibenzyl-2,4-dioxoimidazolidin-1-yl]-N-[3-methyl-1-[5-[(3-methylphenyl)methyl]-1,3,4-oxadiazol-2-yl]-1-oxobutan-2-yl]acetamide;N-[3-methyl-1-[5-[(3-methylphenyl)methyl]-1,3,4-oxadiazol-2-yl]-1-oxobutan-2-yl]-2-[3-(2-morpholin-4-ylethyl)-2,5-dioxo-4-phenylimidazolidin-1-yl]acetamide;N-[3-methyl-1-oxo-1-[5-[[3-(trifluoromethyl)phenyl]methyl]-1,2,4-oxadiazol-3-yl]butan-2-yl]-2-[3-(2-morpholin-4-ylethyl)-2,5-dioxo-4-phenylimidazolidin-1-yl]acetamide;pyridin-4-ylmethyl N-[(2S)-3-methyl-1-[(2S)-2-[[(2S)-3-methyl-1-[5-[(3-methylphenyl)methyl]-1,3,4-oxadiazol-2-yl]-1-oxobutan-2-yl]carbamoyl]pyrrolidin-1-yl]-1-oxobutan-2-yl]carbamate
• PubChem CID: 159208112
• Molecular Formula: C168H186F6N28O30
• Molecular Weight: 3191.49 g/mol
• Exact Mass: 3189.38
• IUPAC Name: 2-[(2S)-2-benzyl-4-(2,3-dihydro-1,4-benzodioxin-6-ylmethyl)-3,6-dioxopiperazin-1-yl]-N-[3-methyl-1-[5-[[3-methyl-5-(trifluoromethyl)phenyl]methyl]-1,3,4-oxadiazol-2-yl]-1-oxobutan-2-yl]acetamide;2-[(5S)-3,5-dibenzyl-2,4-dioxoimidazolidin-1-yl]-N-[3-methyl-1-[5-[(3-methylphenyl)methyl]-1,3,4-oxadiazol-2-yl]-1-oxobutan-2-yl]acetamide;N-[3-methyl-1-[5-[(3-methylphenyl)methyl]-1,3,4-oxadiazol-2-yl]-1-oxobutan-2-yl]-2-[3-(2-morpholin-4-ylethyl)-2,5-dioxo-4-phenylimidazolidin-1-yl]acetamide;N-[3-methyl-1-oxo-1-[5-[[3-(trifluoromethyl)phenyl]methyl]-1,2,4-oxadiazol-3-yl]butan-2-yl]-2-[3-(2-morpholin-4-ylethyl)-2,5-dioxo-4-phenylimidazolidin-1-yl]acetamide;pyridin-4-ylmethyl N-[(2S)-3-methyl-1-[(2S)-2-[[(2S)-3-methyl-1-[5-[(3-methylphenyl)methyl]-1,3,4-oxadiazol-2-yl]-1-oxobutan-2-yl]carbamoyl]pyrrolidin-1-yl]-1-oxobutan-2-yl]carbamate
• SMILES: CC(C)C(NC(=O)CN1C(=O)C(c2ccccc2)N(CCN2CCOCC2)C1=O)C(=O)c1noc(Cc2cccc(C(F)(F)F)c2)n1.Cc1cc(Cc2nnc(C(=O)C(NC(=O)CN3C(=O)CN(Cc4ccc5c(c4)OCCO5)C(=O)[C@@H]3Cc3ccccc3)C(C)C)o2)cc(C(F)(F)F)c1.Cc1cccc(Cc2nnc(C(=O)C(NC(=O)CN3C(=O)C(c4ccccc4)N(CCN4CCOCC4)C3=O)C(C)C)o2)c1.Cc1cccc(Cc2nnc(C(=O)C(NC(=O)CN3C(=O)N(Cc4ccccc4)C(=O)[C@@H]3Cc3ccccc3)C(C)C)o2)c1.Cc1cccc(Cc2nnc(C(=O)[C@@H](NC(=O)[C@@H]3CCCN3C(=O)[C@@H](NC(=O)OCc3ccncc3)C(C)C)C(C)C)o2)c1
• InChI: InChI=1S/C38H38F3N5O7.C34H35N5O5.C32H35F3N6O6.C32H38N6O6.C32H40N6O6/c1-22(2)34(35(49)36-44-43-32(53-36)18-26-13-23(3)14-27(15-26)38(39,40)41)42-31(47)20-46-28(16-24-7-5-4-6-8-24)37(50)45(21-33(46)48)19-25-9-10-29-30(17-25)52-12-11-51-29;1-22(2)30(31(41)32-37-36-29(44-32)19-26-16-10-11-23(3)17-26)35-28(40)21-38-27(18-24-12-6-4-7-13-24)33(42)39(34(38)43)20-25-14-8-5-9-15-25;1-20(2)26(28(43)29-37-25(47-38-29)18-21-7-6-10-23(17-21)32(33,34)35)36-24(42)19-41-30(44)27(22-8-4-3-5-9-22)40(31(41)45)12-11-39-13-15-46-16-14-39;1-21(2)27(29(40)30-35-34-26(44-30)19-23-9-7-8-22(3)18-23)33-25(39)20-38-31(41)28(24-10-5-4-6-11-24)37(32(38)42)13-12-36-14-16-43-17-15-36;1-19(2)26(28(39)30-37-36-25(44-30)17-23-9-6-8-21(5)16-23)34-29(40)24-10-7-15-38(24)31(41)27(20(3)4)35-32(42)43-18-22-11-13-33-14-12-22/h4-10,13-15,17,22,28,34H,11-12,16,18-21H2,1-3H3,(H,42,47);4-17,22,27,30H,18-21H2,1-3H3,(H,35,40);3-10,17,20,26-27H,11-16,18-19H2,1-2H3,(H,36,42);4-11,18,21,27-28H,12-17,19-20H2,1-3H3,(H,33,39);6,8-9,11-14,16,19-20,24,26-27H,7,10,15,17-18H2,1-5H3,(H,34,40)(H,35,42)/t28-,34?;27-,30?;;;24-,26-,27-/m00..0/s1
• InChIKey: KQDGWKKESRSRCX-BBTOUPDQSA-N
• XLogP: 18.53
• TPSA: 702.86 Ų
• H-Bond Donors: 6
• H-Bond Acceptors: 43
• Rotatable Bonds: 60
• Heavy Atoms: 232
• Complexity: —

Lipinski Rule of Five

4 violations

Rule	Value
MW ≤ 500	3191.49
LogP ≤ 5	18.53
H-Bond Donors ≤ 5	6
H-Bond Acceptors ≤ 10	43

Computed Properties (RDKit)

• Structural Alerts: {'alert_name': 'hydantoin', 'substructure': 'N/A'}

Frequently Asked Questions

What is the IUPAC name of 2-[(2S)-2-benzyl-4-(2,3-dihydro-1,4-benzodioxin-6-ylmethyl)-3,6-dioxopiperazin-1-yl]-N-[3-methyl-1-[5-[[3-methyl-5-(trifluoromethyl)phenyl]methyl]-1,3,4-oxadiazol-2-yl]-1-oxobutan-2-yl]acetamide;2-[(5S)-3,5-dibenzyl-2,4-dioxoimidazolidin-1-yl]-N-[3-methyl-1-[5-[(3-methylphenyl)methyl]-1,3,4-oxadiazol-2-yl]-1-oxobutan-2-yl]acetamide;N-[3-methyl-1-[5-[(3-methylphenyl)methyl]-1,3,4-oxadiazol-2-yl]-1-oxobutan-2-yl]-2-[3-(2-morpholin-4-ylethyl)-2,5-dioxo-4-phenylimidazolidin-1-yl]acetamide;N-[3-methyl-1-oxo-1-[5-[[3-(trifluoromethyl)phenyl]methyl]-1,2,4-oxadiazol-3-yl]butan-2-yl]-2-[3-(2-morpholin-4-ylethyl)-2,5-dioxo-4-phenylimidazolidin-1-yl]acetamide;pyridin-4-ylmethyl N-[(2S)-3-methyl-1-[(2S)-2-[[(2S)-3-methyl-1-[5-[(3-methylphenyl)methyl]-1,3,4-oxadiazol-2-yl]-1-oxobutan-2-yl]carbamoyl]pyrrolidin-1-yl]-1-oxobutan-2-yl]carbamate?

The IUPAC name of 2-[(2S)-2-benzyl-4-(2,3-dihydro-1,4-benzodioxin-6-ylmethyl)-3,6-dioxopiperazin-1-yl]-N-[3-methyl-1-[5-[[3-methyl-5-(trifluoromethyl)phenyl]methyl]-1,3,4-oxadiazol-2-yl]-1-oxobutan-2-yl]acetamide;2-[(5S)-3,5-dibenzyl-2,4-dioxoimidazolidin-1-yl]-N-[3-methyl-1-[5-[(3-methylphenyl)methyl]-1,3,4-oxadiazol-2-yl]-1-oxobutan-2-yl]acetamide;N-[3-methyl-1-[5-[(3-methylphenyl)methyl]-1,3,4-oxadiazol-2-yl]-1-oxobutan-2-yl]-2-[3-(2-morpholin-4-ylethyl)-2,5-dioxo-4-phenylimidazolidin-1-yl]acetamide;N-[3-methyl-1-oxo-1-[5-[[3-(trifluoromethyl)phenyl]methyl]-1,2,4-oxadiazol-3-yl]butan-2-yl]-2-[3-(2-morpholin-4-ylethyl)-2,5-dioxo-4-phenylimidazolidin-1-yl]acetamide;pyridin-4-ylmethyl N-[(2S)-3-methyl-1-[(2S)-2-[[(2S)-3-methyl-1-[5-[(3-methylphenyl)methyl]-1,3,4-oxadiazol-2-yl]-1-oxobutan-2-yl]carbamoyl]pyrrolidin-1-yl]-1-oxobutan-2-yl]carbamate (CID 159208112) is 2-[(2S)-2-benzyl-4-(2,3-dihydro-1,4-benzodioxin-6-ylmethyl)-3,6-dioxopiperazin-1-yl]-N-[3-methyl-1-[5-[[3-methyl-5-(trifluoromethyl)phenyl]methyl]-1,3,4-oxadiazol-2-yl]-1-oxobutan-2-yl]acetamide;2-[(5S)-3,5-dibenzyl-2,4-dioxoimidazolidin-1-yl]-N-[3-methyl-1-[5-[(3-methylphenyl)methyl]-1,3,4-oxadiazol-2-yl]-1-oxobutan-2-yl]acetamide;N-[3-methyl-1-[5-[(3-methylphenyl)methyl]-1,3,4-oxadiazol-2-yl]-1-oxobutan-2-yl]-2-[3-(2-morpholin-4-ylethyl)-2,5-dioxo-4-phenylimidazolidin-1-yl]acetamide;N-[3-methyl-1-oxo-1-[5-[[3-(trifluoromethyl)phenyl]methyl]-1,2,4-oxadiazol-3-yl]butan-2-yl]-2-[3-(2-morpholin-4-ylethyl)-2,5-dioxo-4-phenylimidazolidin-1-yl]acetamide;pyridin-4-ylmethyl N-[(2S)-3-methyl-1-[(2S)-2-[[(2S)-3-methyl-1-[5-[(3-methylphenyl)methyl]-1,3,4-oxadiazol-2-yl]-1-oxobutan-2-yl]carbamoyl]pyrrolidin-1-yl]-1-oxobutan-2-yl]carbamate.

What is the SMILES notation for 2-[(2S)-2-benzyl-4-(2,3-dihydro-1,4-benzodioxin-6-ylmethyl)-3,6-dioxopiperazin-1-yl]-N-[3-methyl-1-[5-[[3-methyl-5-(trifluoromethyl)phenyl]methyl]-1,3,4-oxadiazol-2-yl]-1-oxobutan-2-yl]acetamide;2-[(5S)-3,5-dibenzyl-2,4-dioxoimidazolidin-1-yl]-N-[3-methyl-1-[5-[(3-methylphenyl)methyl]-1,3,4-oxadiazol-2-yl]-1-oxobutan-2-yl]acetamide;N-[3-methyl-1-[5-[(3-methylphenyl)methyl]-1,3,4-oxadiazol-2-yl]-1-oxobutan-2-yl]-2-[3-(2-morpholin-4-ylethyl)-2,5-dioxo-4-phenylimidazolidin-1-yl]acetamide;N-[3-methyl-1-oxo-1-[5-[[3-(trifluoromethyl)phenyl]methyl]-1,2,4-oxadiazol-3-yl]butan-2-yl]-2-[3-(2-morpholin-4-ylethyl)-2,5-dioxo-4-phenylimidazolidin-1-yl]acetamide;pyridin-4-ylmethyl N-[(2S)-3-methyl-1-[(2S)-2-[[(2S)-3-methyl-1-[5-[(3-methylphenyl)methyl]-1,3,4-oxadiazol-2-yl]-1-oxobutan-2-yl]carbamoyl]pyrrolidin-1-yl]-1-oxobutan-2-yl]carbamate?

The canonical SMILES for 2-[(2S)-2-benzyl-4-(2,3-dihydro-1,4-benzodioxin-6-ylmethyl)-3,6-dioxopiperazin-1-yl]-N-[3-methyl-1-[5-[[3-methyl-5-(trifluoromethyl)phenyl]methyl]-1,3,4-oxadiazol-2-yl]-1-oxobutan-2-yl]acetamide;2-[(5S)-3,5-dibenzyl-2,4-dioxoimidazolidin-1-yl]-N-[3-methyl-1-[5-[(3-methylphenyl)methyl]-1,3,4-oxadiazol-2-yl]-1-oxobutan-2-yl]acetamide;N-[3-methyl-1-[5-[(3-methylphenyl)methyl]-1,3,4-oxadiazol-2-yl]-1-oxobutan-2-yl]-2-[3-(2-morpholin-4-ylethyl)-2,5-dioxo-4-phenylimidazolidin-1-yl]acetamide;N-[3-methyl-1-oxo-1-[5-[[3-(trifluoromethyl)phenyl]methyl]-1,2,4-oxadiazol-3-yl]butan-2-yl]-2-[3-(2-morpholin-4-ylethyl)-2,5-dioxo-4-phenylimidazolidin-1-yl]acetamide;pyridin-4-ylmethyl N-[(2S)-3-methyl-1-[(2S)-2-[[(2S)-3-methyl-1-[5-[(3-methylphenyl)methyl]-1,3,4-oxadiazol-2-yl]-1-oxobutan-2-yl]carbamoyl]pyrrolidin-1-yl]-1-oxobutan-2-yl]carbamate is CC(C)C(NC(=O)CN1C(=O)C(c2ccccc2)N(CCN2CCOCC2)C1=O)C(=O)c1noc(Cc2cccc(C(F)(F)F)c2)n1.Cc1cc(Cc2nnc(C(=O)C(NC(=O)CN3C(=O)CN(Cc4ccc5c(c4)OCCO5)C(=O)[C@@H]3Cc3ccccc3)C(C)C)o2)cc(C(F)(F)F)c1.Cc1cccc(Cc2nnc(C(=O)C(NC(=O)CN3C(=O)C(c4ccccc4)N(CCN4CCOCC4)C3=O)C(C)C)o2)c1.Cc1cccc(Cc2nnc(C(=O)C(NC(=O)CN3C(=O)N(Cc4ccccc4)C(=O)[C@@H]3Cc3ccccc3)C(C)C)o2)c1.Cc1cccc(Cc2nnc(C(=O)[C@@H](NC(=O)[C@@H]3CCCN3C(=O)[C@@H](NC(=O)OCc3ccncc3)C(C)C)C(C)C)o2)c1.

What is the InChIKey of 2-[(2S)-2-benzyl-4-(2,3-dihydro-1,4-benzodioxin-6-ylmethyl)-3,6-dioxopiperazin-1-yl]-N-[3-methyl-1-[5-[[3-methyl-5-(trifluoromethyl)phenyl]methyl]-1,3,4-oxadiazol-2-yl]-1-oxobutan-2-yl]acetamide;2-[(5S)-3,5-dibenzyl-2,4-dioxoimidazolidin-1-yl]-N-[3-methyl-1-[5-[(3-methylphenyl)methyl]-1,3,4-oxadiazol-2-yl]-1-oxobutan-2-yl]acetamide;N-[3-methyl-1-[5-[(3-methylphenyl)methyl]-1,3,4-oxadiazol-2-yl]-1-oxobutan-2-yl]-2-[3-(2-morpholin-4-ylethyl)-2,5-dioxo-4-phenylimidazolidin-1-yl]acetamide;N-[3-methyl-1-oxo-1-[5-[[3-(trifluoromethyl)phenyl]methyl]-1,2,4-oxadiazol-3-yl]butan-2-yl]-2-[3-(2-morpholin-4-ylethyl)-2,5-dioxo-4-phenylimidazolidin-1-yl]acetamide;pyridin-4-ylmethyl N-[(2S)-3-methyl-1-[(2S)-2-[[(2S)-3-methyl-1-[5-[(3-methylphenyl)methyl]-1,3,4-oxadiazol-2-yl]-1-oxobutan-2-yl]carbamoyl]pyrrolidin-1-yl]-1-oxobutan-2-yl]carbamate?

The InChIKey is KQDGWKKESRSRCX-BBTOUPDQSA-N. The full InChI is InChI=1S/C38H38F3N5O7.C34H35N5O5.C32H35F3N6O6.C32H38N6O6.C32H40N6O6/c1-22(2)34(35(49)36-44-43-32(53-36)18-26-13-23(3)14-27(15-26)38(39,40)41)42-31(47)20-46-28(16-24-7-5-4-6-8-24)37(50)45(21-33(46)48)19-25-9-10-29-30(17-25)52-12-11-51-29;1-22(2)30(31(41)32-37-36-29(44-32)19-26-16-10-11-23(3)17-26)35-28(40)21-38-27(18-24-12-6-4-7-13-24)33(42)39(34(38)43)20-25-14-8-5-9-15-25;1-20(2)26(28(43)29-37-25(47-38-29)18-21-7-6-10-23(17-21)32(33,34)35)36-24(42)19-41-30(44)27(22-8-4-3-5-9-22)40(31(41)45)12-11-39-13-15-46-16-14-39;1-21(2)27(29(40)30-35-34-26(44-30)19-23-9-7-8-22(3)18-23)33-25(39)20-38-31(41)28(24-10-5-4-6-11-24)37(32(38)42)13-12-36-14-16-43-17-15-36;1-19(2)26(28(39)30-37-36-25(44-30)17-23-9-6-8-21(5)16-23)34-29(40)24-10-7-15-38(24)31(41)27(20(3)4)35-32(42)43-18-22-11-13-33-14-12-22/h4-10,13-15,17,22,28,34H,11-12,16,18-21H2,1-3H3,(H,42,47);4-17,22,27,30H,18-21H2,1-3H3,(H,35,40);3-10,17,20,26-27H,11-16,18-19H2,1-2H3,(H,36,42);4-11,18,21,27-28H,12-17,19-20H2,1-3H3,(H,33,39);6,8-9,11-14,16,19-20,24,26-27H,7,10,15,17-18H2,1-5H3,(H,34,40)(H,35,42)/t28-,34?;27-,30?;;;24-,26-,27-/m00..0/s1.

What are the key properties of 2-[(2S)-2-benzyl-4-(2,3-dihydro-1,4-benzodioxin-6-ylmethyl)-3,6-dioxopiperazin-1-yl]-N-[3-methyl-1-[5-[[3-methyl-5-(trifluoromethyl)phenyl]methyl]-1,3,4-oxadiazol-2-yl]-1-oxobutan-2-yl]acetamide;2-[(5S)-3,5-dibenzyl-2,4-dioxoimidazolidin-1-yl]-N-[3-methyl-1-[5-[(3-methylphenyl)methyl]-1,3,4-oxadiazol-2-yl]-1-oxobutan-2-yl]acetamide;N-[3-methyl-1-[5-[(3-methylphenyl)methyl]-1,3,4-oxadiazol-2-yl]-1-oxobutan-2-yl]-2-[3-(2-morpholin-4-ylethyl)-2,5-dioxo-4-phenylimidazolidin-1-yl]acetamide;N-[3-methyl-1-oxo-1-[5-[[3-(trifluoromethyl)phenyl]methyl]-1,2,4-oxadiazol-3-yl]butan-2-yl]-2-[3-(2-morpholin-4-ylethyl)-2,5-dioxo-4-phenylimidazolidin-1-yl]acetamide;pyridin-4-ylmethyl N-[(2S)-3-methyl-1-[(2S)-2-[[(2S)-3-methyl-1-[5-[(3-methylphenyl)methyl]-1,3,4-oxadiazol-2-yl]-1-oxobutan-2-yl]carbamoyl]pyrrolidin-1-yl]-1-oxobutan-2-yl]carbamate?

2-[(2S)-2-benzyl-4-(2,3-dihydro-1,4-benzodioxin-6-ylmethyl)-3,6-dioxopiperazin-1-yl]-N-[3-methyl-1-[5-[[3-methyl-5-(trifluoromethyl)phenyl]methyl]-1,3,4-oxadiazol-2-yl]-1-oxobutan-2-yl]acetamide;2-[(5S)-3,5-dibenzyl-2,4-dioxoimidazolidin-1-yl]-N-[3-methyl-1-[5-[(3-methylphenyl)methyl]-1,3,4-oxadiazol-2-yl]-1-oxobutan-2-yl]acetamide;N-[3-methyl-1-[5-[(3-methylphenyl)methyl]-1,3,4-oxadiazol-2-yl]-1-oxobutan-2-yl]-2-[3-(2-morpholin-4-ylethyl)-2,5-dioxo-4-phenylimidazolidin-1-yl]acetamide;N-[3-methyl-1-oxo-1-[5-[[3-(trifluoromethyl)phenyl]methyl]-1,2,4-oxadiazol-3-yl]butan-2-yl]-2-[3-(2-morpholin-4-ylethyl)-2,5-dioxo-4-phenylimidazolidin-1-yl]acetamide;pyridin-4-ylmethyl N-[(2S)-3-methyl-1-[(2S)-2-[[(2S)-3-methyl-1-[5-[(3-methylphenyl)methyl]-1,3,4-oxadiazol-2-yl]-1-oxobutan-2-yl]carbamoyl]pyrrolidin-1-yl]-1-oxobutan-2-yl]carbamate has a molecular weight of 3191.49 g/mol, XLogP of 18.53, 60 rotatable bonds, 6 hydrogen bond donors, and 43 hydrogen bond acceptors.

Where does this data come from?

All data for 2-[(2S)-2-benzyl-4-(2,3-dihydro-1,4-benzodioxin-6-ylmethyl)-3,6-dioxopiperazin-1-yl]-N-[3-methyl-1-[5-[[3-methyl-5-(trifluoromethyl)phenyl]methyl]-1,3,4-oxadiazol-2-yl]-1-oxobutan-2-yl]acetamide;2-[(5S)-3,5-dibenzyl-2,4-dioxoimidazolidin-1-yl]-N-[3-methyl-1-[5-[(3-methylphenyl)methyl]-1,3,4-oxadiazol-2-yl]-1-oxobutan-2-yl]acetamide;N-[3-methyl-1-[5-[(3-methylphenyl)methyl]-1,3,4-oxadiazol-2-yl]-1-oxobutan-2-yl]-2-[3-(2-morpholin-4-ylethyl)-2,5-dioxo-4-phenylimidazolidin-1-yl]acetamide;N-[3-methyl-1-oxo-1-[5-[[3-(trifluoromethyl)phenyl]methyl]-1,2,4-oxadiazol-3-yl]butan-2-yl]-2-[3-(2-morpholin-4-ylethyl)-2,5-dioxo-4-phenylimidazolidin-1-yl]acetamide;pyridin-4-ylmethyl N-[(2S)-3-methyl-1-[(2S)-2-[[(2S)-3-methyl-1-[5-[(3-methylphenyl)methyl]-1,3,4-oxadiazol-2-yl]-1-oxobutan-2-yl]carbamoyl]pyrrolidin-1-yl]-1-oxobutan-2-yl]carbamate is sourced from PubChem (CID 159208112), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).